Clinical Trial Update: Application and Exploration of Personalized ctDNA-MRD Detection Technology in Predicting the Efficacy of Neoadjuvant Therapy for Rectal Cancer

View source ↗

Summary

This clinical trial analyzes personalized ctDNA minimal residual disease detection to predict the efficacy of neoadjuvant therapy in locally advanced rectal can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: Locally Advanced Rectal Cancer (LARC) | Status: RECRUITING